Affiliation:
1. Aflac Cancer & Blood Disorders Center Emory University Atlanta Georgia USA
Abstract
AbstractThis review describes the current challenges and recommendations in the transfusion management of thalassemia patients. In addition, it reviews the components of blood safety and blood product modification in special populations. Adverse transfusion reactions are described as are some of the newer technologies being utilized to reduce potential transfusion‐associated pathogens. Lastly, research in blood storage and in manufactured blood is briefly described.
Subject
History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience
Reference41 articles.
1. Challenges of blood transfusions in β-thalassemia
2. Challenges in chronic transfusion for patients with thalassemia
3. American Society of Hematology. (2022).Statement on a strong blood supply. Retrieved fromhttps://www.hematology.org/advocacy/policy‐news‐statements‐testimony‐and‐correspondence/policy‐statements/2021/statement‐on‐a‐strong‐blood‐supply
4. Is there a standard-of-care for transfusion therapy in thalassemia?